Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene.

Eichinger S, Minar E, Hirschl M, Bialonczyk C, Stain M, Mannhalter C, Stümpflen A, Schneider B, Lechner K, Kyrle PA.

Thromb Haemost. 1999 Jan;81(1):14-7.

PMID:
10348706
3.

Oral anticoagulant therapy in venous thromboembolism.

Cosmi B, Palareti G.

Semin Vasc Med. 2003 Aug;3(3):303-14. Review.

PMID:
15199464
4.

The role of genetics in the risk of thromboembolism: prothrombin 20210A and oral contraceptive therapy.

Welker GC, Lookinland S, Tiedeman ME, Beckstrand RL.

J Am Acad Nurse Pract. 2004 Mar;16(3):106-15, 138. Review.

PMID:
15130065
5.

Extended treatment for venous thromboembolism: how long is long enough?

Cosmi B, Palareti G.

Curr Hematol Rep. 2004 Sep;3(5):375-81. Review.

PMID:
15341706
6.

[Duration of oral anticoagulant therapy in venous thromboembolism].

Pinède L.

Rev Med Interne. 2001 Dec;22(12):1225-36. Review. French.

PMID:
11794893
7.

Oral anticoagulants for the treatment of venous thromboembolism.

Ansell JE.

Baillieres Clin Haematol. 1998 Sep;11(3):639-61. Review.

PMID:
10331097
8.

Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment.

Roach RE, Cannegieter SC, Lijfering WM.

J Thromb Haemost. 2014 Oct;12(10):1593-600. doi: 10.1111/jth.12678. Epub 2014 Aug 26. Review.

9.

Acquired and congenital risk factors associated with cerebral venous sinus thrombosis.

McBane RD 2nd, Tafur A, Wysokinski WE.

Thromb Res. 2010 Aug;126(2):81-7. doi: 10.1016/j.thromres.2010.04.015. Epub 2010 Jun 11. Review.

PMID:
20541240
10.

[Prevention of venous thromboses with oral anticoagulants].

Hach-Wunderle V, Scharrer I.

Wien Med Wochenschr. 1989 Dec 15;139(23):559-62. Review. German.

PMID:
2696215
11.

Prothrombin 20209C>T: 16 new cases, association with the 19911A>G polymorphism, and literature review.

Warshawsky I, Makkar V, Rimmerman C, Kottke-Marchant K.

J Thromb Haemost. 2009 Sep;7(9):1585-7. doi: 10.1111/j.1538-7836.2009.03513.x. Epub 2009 Jun 9. Review. No abstract available.

12.

Duration of anticoagulant treatment after venous thromboembolism.

Becattini C, Agnelli G.

Pathophysiol Haemost Thromb. 2003 Sep-2004 Dec;33(5-6):354-7. Review. No abstract available.

PMID:
15692243
13.

Venous thrombosis: understanding the paradoxes of recurrence.

Cannegieter SC, van Hylckama Vlieg A.

J Thromb Haemost. 2013 Jun;11 Suppl 1:161-9. doi: 10.1111/jth.12263. Review.

Supplemental Content

Support Center